November 9, 2007 - Recent surveys from Centers for Disease Control and the Association for Professionals in Infection Control and Epidemiology (APIC) have raised awareness of the threat of hospital and community acquired infections including Methicillin-resistant Staphylococcus aureus (MRSA), and the APIC recommends six simple steps to help protect against infections and stop the spread of MRSA in healthcare and community.

In the community environment:

November 9, 2007 - Bayer HealthCare Pharmaceuticals announced that the company has been awarded a three-year contract renewal by HealthTrust Purchasing Group, LP (HealthTrust), to make Magnevist (gadopentetate dimeglumine) Injection available to members of the HealthTrust network.

Magnevist is used to enhance certain MRI procedures, and reportedly has the broadest range of FDA approved indications of any MRI contrast agent for adult and pediatric patients.

November 9, 2007 - Matrox Graphics announced that Cedara Software is using Matrox 10-bit MED Series display controller boards to develop a 10-bit version of the Cedara I-ReadMammo 6.2 mammography software.

Cedara's work-in-progress 10-bit I-ReadMammo application will reportedly be able to display images with up to 1,024 simultaneous levels of gray, when combined with a Matrox 10-bit board and 10-bit displays. This feature aims to provide medical professionals with a more detailed image for more accurate diagnoses.

November 9, 2007 - Clinicians at BC Cancer Agency have treated a prostate cancer patient with a technique, called volumetric arc therapy (VMAT), allowing clinicians to deliver a single treatment to their 72-year-old patient in less than two minutes.

November 9, 2007 – TeraRecon received the Frost & Sullivan 2007 Market Penetration Leadership Award for demonstrating strategic excellence in product innovation, marketing and sales strategies that resulted in the both the largest gain in market share and an outstanding financial performance over the past two to three years.